A recent study from Abdominal Radiology evaluated the prognostic role of radiomics in patients with intrahepatic mass-forming cholangiocarcinoma (IMCC) using contrast-enhanced CT. This study showed that the radiomic features of IMCC are valid prognostic descriptors that also predict patients’ survival in relation to different treatment modalities.